When results start coming through, there will be a belated realization of the potential.
There are currently around 7,000 known monogenic diseases caused by mutations in a single gene. However, a recent study identified 72 monogenic disorders that have a prevalence of at least 1 in 20,000 individuals in the human population. Of these, 34 are caused exclusively by mutations in a single gene. The number of known monogenic diseases continues to grow as gene discovery efforts advance, aided by technologies like whole exome/genome sequencing.
https://pubmed.ncbi.nlm.nih.gov/34515378/
Stoke therapeutics have identified approximately 1,200 monogenic diseases and approximately 6,500 additional genes with RNA target signatures which we believe to be amenable to TANGO.
- Forums
- ASX - By Stock
- PYC
- Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease, page-10
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $863.2M |
Open | High | Low | Value | Volume |
19.0¢ | 19.0¢ | 18.5¢ | $165.9K | 879.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 56706 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 201871 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 74706 | 0.185 |
9 | 274087 | 0.180 |
7 | 260950 | 0.175 |
11 | 530063 | 0.170 |
11 | 272011 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 201871 | 8 |
0.195 | 331897 | 11 |
0.200 | 567691 | 11 |
0.205 | 625000 | 4 |
0.210 | 1015560 | 10 |
Last trade - 14.14pm 04/11/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |